VintaBio’s assignee is seeking bids for its cGMP facility, equipment and proprietary AAV technology as gene therapy contract ...

Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance ...

The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case ...

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical ...

The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, ...

The agreement with the UK Health Security Agency will see the Danish vaccine manufacturer supply its MVA-BN mpox and smallpox ...

New rapid sterility testing capability provides eligible products with results in approximately 3–7 days through automated, ...

VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but ...

The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands ...

Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strateg ...

A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent ...